ArticleFrontiers in medicine2026
Infectious disease outcomes in end-stage renal disease: the influence of dialysis type on patient vulnerability in Hail region.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infections are a major threat to patients with end-stage renal disease (ESRD) receiving renal replacement therapy. Hemodialysis (HD) and peritoneal dialysis (PD) differ in access type, exposure to healthcare environments, and infection pathways, leading to distinct risks for catheter-related bloodstream infection (CRBSI), peritonitis, hospitalization, and adverse outcomes. Recognizing local patterns is essential for prevention planning and quality improvement. Aim: To compare dialysis-related infection prevalence, microbiological profiles, hospitalization events, and biochemical factors between HD and PD patients over a 3-year period (2023-2025) in a predominantly Saudi tertiary dialysis cohort, while describing overall documented infections and non-dialysis infection subtypes as secondary outcomes, and to identify potential infection risk factors relevant to local dialysis practice. Results: HD patients were older and had higher rates of diabetes and hypertension. Infection frequency was 18% in HD and 9% in PD. HD patients had higher incident rates of bloodstream infection, most of them catheter-related, whereas PD patients had higher peritonitis incidence. Infection-related hospitalization was higher in HD (12% vs. 6%), and CRP concentrations were higher in the period of infection. HD had a higher prevalence of Conclusion: HD patients had higher infection burden and more severe outcomes compared to PD patients. Prevention strategies specific to the modality, high-profile monitoring and high-performance quality improvement programs targeted to specific dialysis populations are required to reduce the complications arising from infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.